Antibody Discovery
Customer Spotlight: Amgen on AbD and CLD
Find out how Amgen is transforming their antibody discovery and clonal cell line processes with the Berkeley Lights Platform.
Application Note: Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2 Pandemic Virus Using the Opto Viral Neutralization 1.0 Workflow
Learn how to use blocking and binding assays and the Opto Viral Neutralization 1.0 workflow to identify cross-reactive antibodies that may have broad neutralization capacity across the coronavirus family.
Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets Using the Beacon System
Dr. Shireen Khan presents a case study on how ChemPartner has leveraged the Beacon system to rapidly discover cross-reactive antibodies against the GPI-anchored uPA receptor.
Application Note: Rapid Selection of Antibodies Against Membrane Targets using Cell-Binding Assays and the Opto™ Plasma B Discovery
Find out how the Opto Plasma B Discovery workflow simplifies and dramatically reduces the time needed to down-select potential lead candidates, even for difficult membrane proteins.
Application Note: Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery
Discover how you can maximize hit recovery and rapidly down-select blocking antibodies from plasma B cells in a single day.
Webinar: Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon System
Robert Carnahan, PhD, and Seth Zost, PhD, from the Vanderbilt University Medical Center, describe how they have used the Beacon platform, to rapidly discover hundreds of unique antibodies against SARS-CoV-2.
SynBioBeta Live Roundtable: Can Humanity Build a Global Antibody Defense Barrier Against Future Pandemics?
Listen to the world’s leading experts on antibody discovery to discuss how we can build a global defensive barrier to find new therapeutic antibodies against the coronavirus and future pathogens.
Datasheet: Opto Plasma B Discovery 2.0 Workflow
Review workflow overview and representative results.
Webinar: Antibody Discovery – Select Better Lead Candidates in Under 1 Week
Learn how we enable lead candidate down-selection in 1 day by performing functional characterization during primary screening. Case studies highlight how our customers are dramatically accelerating development of next-generation antibody therapeutics.
Webinar: Accelerating Antibody Discovery in the Modern Therapeutic Landscape
Learn how antibody discovery is changing in today’s therapeutic space. Case studies presented by Abveris highlight accelerated development of next-generation antibody therapeutics.
Webinar: Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics
Watch this on-demand presentation from the 2020 LabRoots Coronavirus Webinar Series to find out how B Cell Antibody Discovery has allowed Berkeley Lights collaborators to discover >500 antibodies to SARS-CoV-2 in a single day.
Application Note: Accessing Greater Antibody Sequence Diversity
See how you can discover >5,000 antigen-specific hits from a single plasma B cell sample and recover >650 unique BCR sequences in under 1 week.
Poster: Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2
Find out how B Cell Antibody Discovery on the Beacon system can be used to rapidly screen human B cell to discover antibodies against difficult targets such as viruses.
Webinar: Antibody Engineering & Therapeutics Digital Week 2019
Learn about accelerating target-to-lead antibody candidate selection with the Beacon platform in this Antibody Engineering & Therapeutics Digital Week 2019 webinar.
Brochure: Antibody Discovery
This 4-page brochure explains how the Beacon platform removes tedious steps from the Antibody Discovery workflow and automates phenotype and genotype screening.
Antibody Discovery Webinar: Digital Week 2018
Watch a 1-hour webinar from the 2018 Antibody Engineering & Therapeutics Digital Week titled, “Emerging Technologies for Finding Rare Antibodies,” featuring scientists from Berkeley Lights and Teva Pharmaceuticals.
Poster: Rapid Antibody Discovery on the Beacon System
This poster developed by Berkeley Lights and Pfizer demonstrates rapid antibody discovery on the Beacon platform, showing how it can rapidly isolate and screen thousands of primary ASCs in a single day.
Poster: Plasma B Cell Cloning
Berkeley Lights and ChemPartner provide a case study in accelerated discovery of unique Anti-PD-L1 antibodies from spleen versus bone marrow of immunized mice, via single plasma B cell cloning on the Beacon platform.